• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国实体器官同种异体移植存活率的提高:长期情况无法反映短期的显著成功。

Solid organ allograft survival improvement in the United States: the long-term does not mirror the dramatic short-term success.

机构信息

Division of Nephrology, Hypertension and Renal Transplantation, Department of Medicine, University of Florida, FL, USA.

出版信息

Am J Transplant. 2011 Jun;11(6):1226-35. doi: 10.1111/j.1600-6143.2011.03539.x. Epub 2011 May 12.

DOI:10.1111/j.1600-6143.2011.03539.x
PMID:21564524
Abstract

Organ survival in the short-term period post-transplant has improved dramatically over the past few decades. Whether this has translated to a long-term survival benefit remains unclear. This study quantifies the progression of nonrenal solid organ transplant outcomes from 1989 to 2009 in liver, lung, heart, intestine and pancreas transplants. Long-term graft survival was analyzed using data on adult solid organ transplant recipients from the UNOS/SRTR database and is reported as organ half-life and yearly attrition rates. Liver, lung, heart, intestine and pancreas half-lives have improved from 5.8 to 8.5, 1.7 to 5.2, 8.8 to 11, 2.1 to 3.6 and 10.5 to 16.7 years, respectively. Long-term attrition rates have not shown the same consistent improvement, with the yearly attrition rate 5-10 years post-transplant for liver, lung, heart and pancreas changing from 4.7 to 4.3, 10.9 to 10.1, 6.4 to 5.1 and 3.3 to 4.2, respectively. Attrition rates for intestine and pancreas transplantation alone display more variability due to smaller sample size but exhibit similar trends of improved first-year attrition and relatively stagnant long-term attrition rates. With first-year survival and attrition rates almost at a pinnacle, further progress in long-term survival will come from targeting endpoints beyond first-year rejection and survival rates.

摘要

在过去的几十年中,器官移植后短期的器官存活率有了显著提高。但这是否转化为长期的生存获益尚不清楚。本研究量化了 1989 年至 2009 年期间肝、肺、心脏、肠和胰腺移植中非肾脏实体器官移植结局的进展情况。使用 UNOS/SRTR 数据库中成人实体器官移植受者的数据来分析长期移植物存活率,并以器官半衰期和年损耗率来报告。肝、肺、心脏、肠和胰腺的半衰期分别从 5.8 年提高到 8.5 年、1.7 年提高到 5.2 年、8.8 年提高到 11 年、2.1 年提高到 3.6 年和 10.5 年提高到 16.7 年。长期损耗率并没有显示出同样的持续改善,肝、肺、心脏和胰腺移植后 5-10 年的年损耗率从 4.7%降至 4.3%、10.9%降至 10.1%、6.4%降至 5.1%和 3.3%降至 4.2%。肠和胰腺移植的损耗率由于样本量较小而显示出更大的变异性,但显示出相似的改善第一年损耗和相对停滞的长期损耗率的趋势。随着第一年的生存率和损耗率几乎达到顶峰,进一步提高长期生存率将需要针对第一年排斥反应和生存率以外的终点。

相似文献

1
Solid organ allograft survival improvement in the United States: the long-term does not mirror the dramatic short-term success.美国实体器官同种异体移植存活率的提高:长期情况无法反映短期的显著成功。
Am J Transplant. 2011 Jun;11(6):1226-35. doi: 10.1111/j.1600-6143.2011.03539.x. Epub 2011 May 12.
2
Lack of significant improvements in long-term allograft survival in pediatric solid organ transplantation: A US national registry analysis.小儿实体器官移植中长期同种异体移植物存活情况缺乏显著改善:一项美国国家登记分析。
Pediatr Transplant. 2015 Aug;19(5):477-83. doi: 10.1111/petr.12465. Epub 2015 Apr 1.
3
Center-specific graft and patient survival rates: 1997 United Network for Organ Sharing (UNOS) report.特定移植中心的移植物和患者存活率:1997年器官共享联合网络(UNOS)报告。
JAMA. 1998 Oct 7;280(13):1153-60. doi: 10.1001/jama.280.13.1153.
4
Outcome of kidney transplant in primary, repeat, and kidney-after-nonrenal solid-organ transplantation: 15-year analysis of recent UNOS database.初次、再次及非肾实体器官移植后肾移植的结局:对近期器官共享联合网络(UNOS)数据库的15年分析
Clin Transplant. 2017 Nov;31(11). doi: 10.1111/ctr.13108. Epub 2017 Oct 16.
5
Long-term renal allograft survival in the United States: a critical reappraisal.美国的长期肾脏移植物存活率:批判性再评估。
Am J Transplant. 2011 Mar;11(3):450-62. doi: 10.1111/j.1600-6143.2010.03283.x. Epub 2010 Oct 25.
6
Intestine and multivisceral transplantation in the United States: a report of 20-year national registry data (1990-2009).美国的肠道和多脏器移植:20年国家登记数据报告(1990 - 2009年)
Clin Transpl. 2009:83-101.
7
Outcomes of Pediatric Kidney Transplantation in Recipients of a Previous Non-Renal Solid Organ Transplant.儿科肾移植受者中既往非肾脏实体器官移植的结果。
Am J Transplant. 2017 Jul;17(7):1928-1934. doi: 10.1111/ajt.14260. Epub 2017 Mar 30.
8
Pancreas transplant outcomes for United States (US) and non-US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of May 2003.截至2003年5月,向器官共享联合网络(UNOS)和国际胰腺移植登记处(IPTR)报告的美国及非美国病例的胰腺移植结果。
Clin Transpl. 2003:21-51.
9
Pancreas transplant outcomes for United States (US) and non-US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of October 2002.截至2002年10月,向器官共享联合网络(UNOS)和国际胰腺移植登记处(IPTR)报告的美国及非美国病例的胰腺移植结果。
Clin Transpl. 2002:41-77.
10
Solid organ donor-recipient race-matching: analysis of the United Network for Organ Sharing database.实体器官供受者种族匹配:美国器官共享网络数据库分析。
Transpl Int. 2021 Apr;34(4):640-647. doi: 10.1111/tri.13832. Epub 2021 Mar 4.

引用本文的文献

1
Immunosuppressants Rewire the Gut Microbiome-Alloimmune Axis Through Time-Dependent and Tissue-Specific Mechanisms.免疫抑制剂通过时间依赖性和组织特异性机制重塑肠道微生物群-同种免疫轴。
bioRxiv. 2025 Jul 11:2025.01.02.631100. doi: 10.1101/2025.01.02.631100.
2
Changes in esophageal contractile and barrier function in lung transplant recipients.肺移植受者食管收缩和屏障功能的变化。
Esophagus. 2025 Jun 11. doi: 10.1007/s10388-025-01135-6.
3
Macrophage regulated cell death: implications and mechanisms in organ transplantation.巨噬细胞调节的细胞死亡:在器官移植中的意义和机制
Front Immunol. 2025 May 23;16:1604429. doi: 10.3389/fimmu.2025.1604429. eCollection 2025.
4
Tolerogenic Therapies in Cardiac Transplantation.心脏移植中的耐受性疗法
Int J Mol Sci. 2025 Apr 23;26(9):3968. doi: 10.3390/ijms26093968.
5
Replacement as an aging intervention.作为一种衰老干预手段的替代方法。
Nat Aging. 2025 May;5(5):750-764. doi: 10.1038/s43587-025-00858-6. Epub 2025 May 8.
6
From seabed to sickbed: lessons gained from allorecognition in marine invertebrates.从海底到病床:从海洋无脊椎动物的同种异体识别中获得的经验教训。
Front Immunol. 2025 Apr 10;16:1563685. doi: 10.3389/fimmu.2025.1563685. eCollection 2025.
7
Pre-transplant T-cell clonal analysis identifies CD8 donor reactive clones that contribute to kidney transplant rejection.移植前T细胞克隆分析可识别出对肾移植排斥反应有贡献的CD8供体反应性克隆。
Front Immunol. 2025 Feb 6;16:1516772. doi: 10.3389/fimmu.2025.1516772. eCollection 2025.
8
Unlocking Transplant Tolerance with Biomaterials.利用生物材料实现移植耐受
Adv Healthc Mater. 2025 Feb;14(5):e2400965. doi: 10.1002/adhm.202400965. Epub 2024 Jul 3.
9
Lung Transplant Immunomodulation with Genetically Engineered Mesenchymal Stromal Cells-Therapeutic Window for Interleukin-10.肺移植免疫调节中的基因工程间充质基质细胞——白细胞介素-10 的治疗窗。
Cells. 2024 May 17;13(10):859. doi: 10.3390/cells13100859.
10
Plasma concentrations of histidine-rich glycoprotein in primary graft dysfunction after lung transplantation.肺移植术后原发性移植肺功能障碍时富含组氨酸糖蛋白的血浆浓度
Interdiscip Cardiovasc Thorac Surg. 2024 Feb 2;38(2). doi: 10.1093/icvts/ivae021.